Emir, S. Et Al. 2003. Correspondence: Treatment of the neuroblastoma-associated opsocionus-myocionus-ataxia (OMA) syndrome with high-dose methylprednisolone. MEDICAL AND PEDIATRIC ONCOLOGY , vol.40, no.2 , 139.

Emir, S., Akyuz, C., & Buyukpamukcu, M., (2003). Correspondence: Treatment of the neuroblastoma-associated opsocionus-myocionus-ataxia (OMA) syndrome with high-dose methylprednisolone. MEDICAL AND PEDIATRIC ONCOLOGY , vol.40, no.2, 139.

Emir, S, CANAN AKYÜZ, And MÜNEVVER BÜYÜKPAMUKÇU. "Correspondence: Treatment of the neuroblastoma-associated opsocionus-myocionus-ataxia (OMA) syndrome with high-dose methylprednisolone," MEDICAL AND PEDIATRIC ONCOLOGY , vol.40, no.2, 139, 2003

Emir, S Et Al. "Correspondence: Treatment of the neuroblastoma-associated opsocionus-myocionus-ataxia (OMA) syndrome with high-dose methylprednisolone." MEDICAL AND PEDIATRIC ONCOLOGY , vol.40, no.2, pp.139, 2003

Emir, S. Akyuz, C. And Buyukpamukcu, M. (2003) . "Correspondence: Treatment of the neuroblastoma-associated opsocionus-myocionus-ataxia (OMA) syndrome with high-dose methylprednisolone." MEDICAL AND PEDIATRIC ONCOLOGY , vol.40, no.2, p.139.

@article{article, author={S Emir Et Al. }, title={Correspondence: Treatment of the neuroblastoma-associated opsocionus-myocionus-ataxia (OMA) syndrome with high-dose methylprednisolone}, journal={MEDICAL AND PEDIATRIC ONCOLOGY}, year=2003, pages={139} }